🔎 Trials Near Me

Home › Diffuse Large B-Cell Lymphoma › Montana

Diffuse Large B-Cell Lymphoma clinical trials in Montana

3 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in Montana.

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  • Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0178), Billings
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT06717347

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

  • Bozeman Health Deaconess Hospital ( Site 0183), Bozeman
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT06890884

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

  • Billings Clinic Cancer Center, Billings
  • Benefis Sletten Cancer Institute, Great Falls
  • Community Medical Center, Missoula
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06649812

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.